Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Antisera, Fluorescent, Herpesvirus Hominis 1,2

FDA product code GQL · 37 cleared devices

Class 2 Microbiology
Regulation
21 CFR 866.3305
Review panel
MI
Implant
No
Life sustaining
No
Third party review
No
GMP exempt
No
Clearance span
1977-07-11 – 2009-08-28
↑